These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7534602)

  • 1. Regional variations in the pharmacology of AMPA receptors as revealed by receptor autoradiography.
    Porter RH; Greenamyre JT
    Brain Res; 1994 Nov; 664(1-2):202-6. PubMed ID: 7534602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the binding of [3H]NS 257, a novel competitive AMPA receptor antagonist, to rat brain membranes and brain sections.
    Nielsen EO; Johansen TH; Wätjen F; Drejer J
    J Neurochem; 1995 Sep; 65(3):1264-73. PubMed ID: 7543932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology and regional distribution of the binding of 6-[3H]nitro-7-sulphamoylbenzo[f]-quinoxaline-2,3-dione to rat brain.
    Dev KK; Petersen V; Honoré T; Henley JM
    J Neurochem; 1996 Dec; 67(6):2609-12. PubMed ID: 8931496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NS-257, a novel competitive AMPA receptor antagonist, interacts with kainate and NMDA receptors.
    Nijholt I; Blank T; Grafelmann B; Cepok S; Kügler H; Spiess J
    Brain Res; 1999 Mar; 821(2):374-82. PubMed ID: 10064824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes.
    Stein E; Cox JA; Seeburg PH; Verdoorn TA
    Mol Pharmacol; 1992 Nov; 42(5):864-71. PubMed ID: 1279377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic characterization of the non-N-methyl-D-aspartate binding sites in human cerebellum using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione.
    Hatziefthimiou A; Mitsacos A; Kouvelas ED
    J Neurosci Res; 1994 Feb; 37(3):392-7. PubMed ID: 7909852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the non-NMDA receptor antagonist, 2,3-dihydro-6-nitro-7-sulfamoylbenzo(f)quinoxaline, on local cerebral glucose uptake in the limbic forebrain.
    Suzdak PD; Sheardown MJ
    J Neurochem; 1993 Oct; 61(4):1577-80. PubMed ID: 8397300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of prolactin secretion by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in male rats.
    González LC; Pinilla L; Tena-Sempere M; Aguilar E
    J Endocrinol; 2000 Sep; 166(3):669-75. PubMed ID: 10974660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple states of rat brain (RS)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors as revealed by quantitative autoradiography.
    Cha JH; Makowiec RL; Penney JB; Young AB
    Mol Pharmacol; 1992 May; 41(5):832-8. PubMed ID: 1375315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of growth hormone secretion by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in infantile, prepubertal, and adult male rats.
    González LC; Pinilla L; Tena-Sempere M; Aguilar E
    Endocrinology; 1999 Mar; 140(3):1279-84. PubMed ID: 10067854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GYKI 53665, a 2,3-benzodiazepine, non-competitively protects cultured neurones against AMPA toxicity.
    Kovács AD; Szabó G
    Eur J Pharmacol; 1997 Jul; 331(1):93-6. PubMed ID: 9274935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]AMPA binding to glutamate receptor subpopulations in rat brain.
    Olsen RW; Szamraj O; Houser CR
    Brain Res; 1987 Feb; 402(2):243-54. PubMed ID: 2881601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPA receptor modulation in previously frozen mouse brain sections: opposite effects of calcium in the cortex and hippocampus.
    Lapierre L; Valastro B; Miceli D; Massicotte G
    Hippocampus; 2000; 10(6):645-53. PubMed ID: 11153710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of thiocyanate and AMPA receptor ligands on (S)-5-fluorowillardiine, (S)-AMPA and (R,S)-AMPA binding.
    Hawkinson JE; Espitia SA
    Eur J Pharmacol; 1997 Jun; 329(2-3):213-21. PubMed ID: 9226415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of the human ionotropic glutamate receptor subtype GluR3 stably expressed in mammalian cells.
    Varney MA; Rao SP; Jachec C; Deal C; Hess SD; Daggett LP; Lin F; Johnson EC; Veliçelebi G
    J Pharmacol Exp Ther; 1998 Apr; 285(1):358-70. PubMed ID: 9536032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
    Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
    J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the pharmacology and regional distribution of (S)-[3H]-5-fluorowillardiine binding in rat brain.
    Hawkins LM; Beaver KM; Jane DE; Taylor PM; Sunter DC; Roberts PJ
    Br J Pharmacol; 1995 Oct; 116(3):2033-9. PubMed ID: 8640342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPA receptor antagonists and local cerebral glucose utilization in the rat.
    Browne SE; McCulloch J
    Brain Res; 1994 Mar; 641(1):10-20. PubMed ID: 8019834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A crucial role of the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype of glutamate receptors in piriform and perirhinal cortex for the initiation and propagation of limbic motor seizures.
    Tortorella A; Halonen T; Sahibzada N; Gale K
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1401-5. PubMed ID: 9067329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.